| The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions H Bolouri, JE Farrar, T Triche Jr, RE Ries, EL Lim, TA Alonzo, Y Ma, ... Nature medicine 24 (1), 103-112, 2018 | 651 | 2018 |
| Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase … AS Gamis, TA Alonzo, S Meshinchi, L Sung, RB Gerbing, SC Raimondi, ... Journal of Clinical Oncology 32 (27), 3021, 2014 | 445 | 2014 |
| Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group MR Loken, TA Alonzo, L Pardo, RB Gerbing, SC Raimondi, BA Hirsch, ... Blood, The Journal of the American Society of Hematology 120 (8), 1581-1588, 2012 | 307 | 2012 |
| Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971 AS Gamis, TA Alonzo, RB Gerbing, JM Hilden, AD Sorrell, M Sharma, ... Blood, The Journal of the American Society of Hematology 118 (26), 6752-6759, 2011 | 242 | 2011 |
| Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis G Mundschau, S Gurbuxani, AS Gamis, ME Greene, RJ Arceci, ... Blood 101 (11), 4298-4300, 2003 | 238 | 2003 |
| AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children … TM Cooper, J Franklin, RB Gerbing, TA Alonzo, C Hurwitz, SC Raimondi, ... Cancer 118 (3), 761-769, 2012 | 215 | 2012 |
| Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children’s Cancer Group … AS Gamis, WG Woods, TA Alonzo, A Buxton, B Lange, DR Barnard, ... Journal of Clinical Oncology 21 (18), 3415-3422, 2003 | 171 | 2003 |
| Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL Q Wen, B Goldenson, SJ Silver, M Schenone, V Dancik, Z Huang, ... Cell 150 (3), 575-589, 2012 | 158 | 2012 |
| Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and Bayesian dose personalization JS McCune, MJ Bemer, JS Barrett, K Scott Baker, AS Gamis, NHG Holford Clinical Cancer Research 20 (3), 754-763, 2014 | 153 | 2014 |
| Genomic profiling of pediatric acute myeloid leukemia reveals a changing mutational landscape from disease diagnosis to relapse JE Farrar, HL Schuback, RE Ries, D Wai, OA Hampton, LR Trevino, ... Cancer research 76 (8), 2197-2205, 2016 | 152 | 2016 |
| CD33 splicing polymorphism determines gemtuzumab ozogamicin response in de novo acute myeloid leukemia: report from randomized phase III Children’s Oncology Group trial AAML0531 JK Lamba, L Chauhan, M Shin, MR Loken, JA Pollard, YC Wang, RE Ries, ... Journal of Clinical Oncology 35 (23), 2674, 2017 | 147 | 2017 |
| CD33 expression and its association with gemtuzumab ozogamicin response: results from the randomized phase III Children’s Oncology Group Trial AAML0531 JA Pollard, M Loken, RB Gerbing, SC Raimondi, BA Hirsch, R Aplenc, ... Journal of clinical oncology 34 (7), 747, 2016 | 132 | 2016 |
| Leukemic mutations in the methylation‐associated genes DNMT3A and IDH2 are rare events in pediatric AML: A report from the Children's Oncology Group PA Ho, MA Kutny, TA Alonzo, RB Gerbing, J Joaquin, SC Raimondi, ... Pediatric blood & cancer 57 (2), 204-209, 2011 | 132 | 2011 |
| NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report F Ostronoff, M Othus, RB Gerbing, MR Loken, SC Raimondi, BA Hirsch, ... Blood, The Journal of the American Society of Hematology 124 (15), 2400-2407, 2014 | 125 | 2014 |
| Nitrous oxide analgesia in a pediatric emergency department AS Gamis, JF Knapp, JA Glenski Annals of emergency medicine 18 (2), 177-181, 1989 | 120 | 1989 |
| Infections and association with different intensity of chemotherapy in children with acute myeloid leukemia L Sung, A Gamis, TA Alonzo, A Buxton, K Britton, J DeSwarte‐Wallace, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2009 | 119 | 2009 |
| Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children’s Oncology Group L Sung, R Aplenc, TA Alonzo, RB Gerbing, T Lehrnbecher, AS Gamis Blood, The Journal of the American Society of Hematology 121 (18), 3573-3577, 2013 | 118 | 2013 |
| Disseminated Infection with Fusarium in Recipients of Bone Marrow Transplants AS Gamis, T Gudnason, GS Giebink, NKC Ramsay Reviews of infectious diseases 13 (6), 1077-1088, 1991 | 115 | 1991 |
| Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemia AS Gamis, TA Alonzo, JP Perentesis, S Meshinchi, ... Pediatric blood & cancer 60 (6), 964-971, 2013 | 114 | 2013 |
| Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study PA Ho, TA Alonzo, KJ Kopecky, KL Miller, J Kuhn, R Zeng, RB Gerbing, ... Leukemia 24 (5), 909-913, 2010 | 112 | 2010 |
